
MDB · Nasdaq
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.46B | $2.01B | $1.68B | $1.28B | $873.78M | $590.38M | $421.72M | $267.02M |
| Cost of Revenue | $696.06M | $535.30M | $424.49M | $349.30M | $259.49M | $177.08M | $125.36M | $73.57M |
| Gross Profit | $1.77B | $1.47B | $1.26B | $934.74M | $614.29M | $413.30M | $296.36M | $193.45M |
| Research & Development | $716.30M | $596.84M | $515.94M | $421.69M | $308.82M | $205.16M | $149.03M | $89.85M |
| Selling, General & Administrative | $244.01M | $219.23M | $193.56M | $160.50M | $122.94M | $92.35M | $71.30M | $53.06M |
| Operating Expenses | $1.90B | $1.69B | $1.49B | $1.28B | $903.65M | $622.61M | $444.23M | $291.21M |
| Operating Income | -$136.97M | -$216.06M | -$233.73M | -$346.65M | -$289.36M | -$209.30M | -$147.87M | -$97.77M |
| Interest Expense | $3.13M | $8.09M | $9.39M | $9.80M | $11.32M | $56.11M | $20.98M | $10.29M |
| Other Income / (Expense) | -$4.19M | -$3.13M | -$635.00K | -$1.75M | -$3.13M | -$1.85M | -$15.88M | -$1.44M |
| Income Before Taxes | -$55.69M | -$131.60M | -$163.52M | -$333.25M | -$302.89M | -$262.69M | -$176.18M | -$102.33M |
| Provision for Income Taxes | $15.46M | -$2.53M | $13.08M | $12.14M | $3.98M | $4.25M | -$656.00K | -$3.32M |
| Net Income | -$71.15M | -$129.07M | -$176.60M | -$345.40M | -$306.87M | -$266.94M | -$175.52M | -$99.01M |
| Basic EPS | -$0.88 | -$1.73 | -$2.48 | -$5.03 | -$4.75 | -$4.53 | — | — |
| Diluted EPS | -$0.88 | -$1.73 | -$2.48 | -$5.03 | -$4.75 | -$4.53 | — | — |
| Basic Shares Outstanding | 81.25M | 74.56M | 71.25M | 68.63M | 64.56M | 58.98M | — | — |
| Diluted Shares Outstanding | 81.25M | 74.56M | 71.25M | 68.63M | 64.56M | 58.98M | — | — |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $0.48 | $0.33 | $0.84 | 11 | ↑11 ↓0 |
| Jan 2028 | $1.47 | $0.11 | $1.93 | 11 | ↑10 ↓0 |
| Jan 2029 | $2.96 | $2.96 | $2.96 | 1 | ↑1 ↓0 |